Association between polymorphisms in the apolipoprotein D gene and sporadic Alzheimer's disease
- PMID: 18671953
- DOI: 10.1016/j.brainres.2008.07.018
Association between polymorphisms in the apolipoprotein D gene and sporadic Alzheimer's disease
Abstract
Apolipoprotein D (apoD) is a lipoprotein-associated glycoprotein that is increased in the hippocampus and cerebrospinal fluid of patients with Alzheimer's disease (AD), which implies that apoD might be involved in the pathogenesis of AD. We used polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) and DNA sequencing techniques to screen all exons (1-5) and the flanking exon-intron boundaries of the apoD gene (APOD). Thirty subjects [15 sporadic AD (SAD) patients and 15 controls] were randomly selected and tested for APOD variations by direct sequencing. Two APOD polymorphisms (rs5952T/C and rs1568566C/T) were detected. We further investigated APOD polymorphisms in 256 SAD patients and 294 healthy subjects from a North Chinese population to investigate whether they affect the risk of SAD. Logistic analysis revealed that both rs5952 C and rs1568566 T alleles increase the risk of SAD [rs5952, adjusted odds ratio (OR) 1.817, 95% confidence interval (CI) 1.237-2.669, P = 0.002; rs1568566, adjusted OR 1.563, 95% CI 1.060-2.306, P = 0.024). The rs5952T-rs1568566C haplotype showed lower risk of SAD (OR 0.421, 95% CI 0.305-0.583, P = 0.000). Case-control analysis revealed that the rs5952T-rs1568566C haplotype could serve as a novel defendant factor against SAD. APOD polymorphisms might play an important role in modifying SAD risk in some way.
Similar articles
-
Association between somatostatin gene polymorphisms and sporadic Alzheimer's disease in Chinese population.Neurosci Lett. 2009 Nov 13;465(2):181-3. doi: 10.1016/j.neulet.2009.09.002. Epub 2009 Sep 4. Neurosci Lett. 2009. PMID: 19733630
-
Lack of association between the polymorphisms of beta-site APP-cleaving enzyme 2 (BACE2) 5'-flanking region and sporadic Alzheimer's disease.Brain Res. 2009 Feb 27;1257:10-5. doi: 10.1016/j.brainres.2008.12.024. Epub 2008 Dec 24. Brain Res. 2009. PMID: 19124009
-
Interleukin-18 promoter polymorphisms and risk of late onset Alzheimer's disease.Brain Res. 2009 Feb 9;1253:169-75. doi: 10.1016/j.brainres.2008.11.083. Epub 2008 Dec 3. Brain Res. 2009. PMID: 19073159
-
Apolipoprotein D takes center stage in the stress response of the aging and degenerative brain.Neurobiol Aging. 2014 Jul;35(7):1632-42. doi: 10.1016/j.neurobiolaging.2014.01.148. Epub 2014 Feb 5. Neurobiol Aging. 2014. PMID: 24612673 Free PMC article. Review.
-
Apolipoprotein E represents a potent gene-based therapeutic target for the treatment of sporadic Alzheimer's disease.Alzheimers Dement. 2008 Jan;4(1 Suppl 1):S91-7. doi: 10.1016/j.jalz.2007.11.012. Alzheimers Dement. 2008. PMID: 18632009 Review. No abstract available.
Cited by
-
Genomics and pharmacogenomics of dementia.CNS Neurosci Ther. 2011 Oct;17(5):566-76. doi: 10.1111/j.1755-5949.2010.00189.x. Epub 2010 Aug 16. CNS Neurosci Ther. 2011. PMID: 20718828 Free PMC article. Review.
-
The Lipocalin Apolipoprotein D Functional Portrait: A Systematic Review.Front Physiol. 2021 Oct 7;12:738991. doi: 10.3389/fphys.2021.738991. eCollection 2021. Front Physiol. 2021. PMID: 34690812 Free PMC article.
-
Diversity and disparity in dementia: the impact of ethnoracial differences in Alzheimer disease.Alzheimer Dis Assoc Disord. 2011 Jul-Sep;25(3):187-95. doi: 10.1097/WAD.0b013e318211c6c9. Alzheimer Dis Assoc Disord. 2011. PMID: 21399486 Free PMC article. Review.
-
ApoD mediates binding of HDL to LDL and to growing T24 carcinoma.PLoS One. 2014 Dec 16;9(12):e115180. doi: 10.1371/journal.pone.0115180. eCollection 2014. PLoS One. 2014. PMID: 25513803 Free PMC article.
-
Cluster expansion of apolipoprotein D (ApoD) genes in teleost fishes.BMC Evol Biol. 2019 Jan 8;19(1):9. doi: 10.1186/s12862-018-1323-x. BMC Evol Biol. 2019. PMID: 30621595 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous